Related Experiment Videos
Mevalonate pathway and isoprenoids regulate human bronchial myocyte proliferation
T Viganõ1, A Hernandez, A Corsini
1Institute of Pharmacological Sciences, University of Milan, Italy.
European Journal of Pharmacology
|October 15, 1995
Summary
Simvastatin, a cholesterol-lowering drug, inhibits human bronchial smooth muscle cell growth. Adding mevalonate or geranylgeraniol reversed this effect, indicating their importance in cell proliferation control.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Cellular proliferation is crucial for tissue homeostasis and is tightly regulated.
- The mevalonate pathway is essential for synthesizing key molecules involved in cell growth.
- Human bronchial myocytes play a role in airway function and remodeling.
Purpose of the Study:
- To investigate the role of mevalonate and geranylgeraniol in controlling human bronchial myocyte proliferation.
- To examine the effects of simvastatin, a mevalonate synthesis inhibitor, on these cells.
Main Methods:
- Utilized cultured human bronchial myocytes.
- Administered simvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
- Assessed cell proliferation rates and the impact of mevalonate and geranylgeraniol supplementation.
Main Results:
- Simvastatin inhibited bronchial smooth muscle cell growth in a concentration-dependent manner (IC50 = 0.97 +/- 0.1 microM).
- Mevalonate (100 microM) and geranylgeraniol (5 microM) restored cell proliferation to control levels when added at non-toxic concentrations.
Conclusions:
- Mevalonate and geranylgeraniol are critical for the proliferation of human bronchial myocytes.
- Inhibition of the mevalonate pathway affects bronchial smooth muscle cell growth.
- These findings highlight potential therapeutic targets for conditions involving bronchial smooth muscle cell proliferation.